11-氧合雄激素作为21-羟化酶缺陷症中肾上腺体积与睾丸肾上腺残余瘤的生物标志物
该横断面研究纳入114例21-羟化酶缺陷症(21OHD)患者,采用质谱法检测23种类固醇,并与骨龄提前、肾上腺体积、睾丸肾上腺残余瘤(TART)、多毛症、月经紊乱及垂体激素进行相关性分析。结果显示总肾上腺体积与18种类固醇正相关,其中21-脱氧皮质醇和四种11-氧合-C19(11oxC19)类固醇相关性最强(r≈0.7,P<0.0001);合并TART的男性中9种类固醇显著升高。结论认为11oxC19类固醇和硫酸孕烯醇酮可能作为21OHD疾病控制与长期并发症的临床有用生物标志物。
要点
- 总肾上腺体积与21-脱氧皮质醇及四种11oxC19类固醇(11OHA4、11ketoA4、11OHT、11ketoT)正相关,r≈0.7,P<0.0001。
- 合并TART的男性中11OHA4升高6.8倍、11OHT升高4.9倍、11ketoT升高3.6倍、11ketoA4升高3.3倍、PregS升高4.8倍(P≤0.01)。
- 青春期后合并月经紊乱的女性中PregS升高28.5倍、17-羟基孕烯醇酮硫酸盐升高19倍(P<0.01)。
核心结论
- 11oxC19类固醇和PregS可能作为21OHD疾病控制与长期并发症的临床有用生物标志物。
研究设计与样本
- 横断面研究,纳入114例21OHD患者(男性70例),年龄2至67岁(中位15岁),就诊于三级转诊中心。
- 采用质谱法检测首次晨药前获得的23种类固醇,并与骨龄提前(儿童)、肾上腺体积(成人)、TART、多毛症、月经紊乱及垂体激素进行相关性分析。
主要发现
- 总肾上腺体积与18种类固醇正相关,其中21-脱氧皮质醇和四种11oxC19类固醇(11OHA4、11ketoA4、11OHT、11ketoT)最为显著(r≈0.7,P<0.0001)。
- 合并TART的男性中9种类固醇显著高于无TART者(P≤0.01),包括11OHA4升高6.8倍、11OHT升高4.9倍、11ketoT升高3.6倍、11ketoA4升高3.3倍、PregS升高4.8倍。
- 青春期后合并月经紊乱的女性中PregS升高28.5倍、17-羟基孕烯醇酮硫酸盐升高19倍(P<0.01)。
- 男性Tanner 1和2期睾酮与所有11oxC19类固醇正相关(r≈0.7,P<0.001),Tanner 5期则负相关(11ketoA4和11ketoT的r=-0.3,P<0.05)。
- 女性所有Tanner分期睾酮与四种11oxC19类固醇均正相关(r≈0.8,P<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Patients with 21-hydroxylase deficiency (21OHD) have long-term complications, resulting from poor disease control and/or glucocorticoid overtreatment. Lack of optimal biomarkers has made it challenging to tailor therapy and predict long-term outcomes. OBJECTIVE: To identify biomarkers of disease control and long-term complications in 21OHD. SETTING AND PARTICIPANTS: Cross-sectional study of 114 patients (70 males), ages 2 to 67 years (median, 15 years), seen in a tertiary referral center. METHODS: We correlated a mass-spectrometry panel of 23 steroids, obtained before first morning medication, with bone age advancement (children), adrenal volume (adults), testicular adrenal rest tumors (TART), hirsutism, menstrual disorders, and pituitary hormones. RESULTS: Total adrenal volume correlated positively with 18 steroids, most prominently 21-deoxycortisol and four 11-oxygenated-C19 (11oxC19) steroids: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11ketoA4), 11β-hydroxytestosterone (11OHT), and 11-ketotestosterone (11ketoT) (r ≈ 0.7, P < 0.0001). Nine steroids were significantly higher (P ≤ 0.01) in males with TART compared with those without TART, including 11OHA4 (6.8-fold), 11OHT (4.9-fold), 11ketoT (3.6-fold), 11ketoA4 (3.3-fold), and pregnenolone sulfate (PregS; 4.8-fold). PregS (28.5-fold) and 17-hydroxypregnenolone sulfate (19-fold) levels were higher (P < 0.01) in postpubertal females with menstrual disorders. In males, testosterone levels correlated positively with all 11oxC19 steroids in Tanner stages 1 and 2 (r ≈ 0.7; P < 0.001) but negatively in Tanner stage 5 (r = -0.3 and P < 0.05 for 11ketoA4 and 11ketoT). In females, testosterone level correlated positively with all four 11oxC19 steroids across all Tanner stages (r ≈ 0.8; P < 0.0001). CONCLUSION: 11oxC19 steroids and PregS might serve as clinically useful biomarkers of disease control and long-term complications in 21OHD.
引用
- Turcu AF, Mallappa A, Elman MS, et al. 11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2017. PMID: 28472487. doi:10.1210/jc.2016-3989
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。